Drug Price Transparency
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|---|---|---|---|---|
| Itovebi | 01/01/2024 | Inavolisib | increased | 972.23 | 100 |
| Itovebi | 01/01/2024 | Inavolisib | increased | 972.23 | 100 |
| Ixchiq | 01/01/2024 | Chikungunya Vaccine, Live/PF | increased | 972.23 | 100 |
| Ixchiq | 01/01/2024 | Chikungunya Vaccine, Live/PF | increased | 972.23 | 100 |
| Ixiaro | 01/01/2024 | Japanese Encephalitis Vacc/PF | increased | 972.23 | 100 |
| Ixiaro | 01/01/2024 | Japanese Encephalitis Vacc/PF | increased | 972.23 | 100 |
| Izervay | 01/01/2024 | Avacincaptad PEGol Sodium/PF | increased | 972.23 | 100 |
| Izervay | 01/01/2024 | Avacincaptad PEGol Sodium/PF | increased | 972.23 | 100 |
| Jadenu Sprinkle | 01/01/2024 | Deferasirox | increased | 972.23 | 100 |
| Jadenu Sprinkle | 01/01/2024 | Deferasirox | increased | 972.23 | 100 |
| Jadenu | 01/01/2024 | Deferasirox | increased | 972.23 | 100 |
| Jadenu | 01/01/2024 | Deferasirox | increased | 972.23 | 100 |
| Jakafi | 01/01/2024 | Ruxolitinib Phosphate | increased | 972.23 | 100 |
| Jakafi | 01/01/2024 | Ruxolitinib Phosphate | increased | 972.23 | 100 |
| Jaypirca | 01/01/2024 | Pirtobrutinib | increased | 972.23 | 100 |
| Jaypirca | 01/01/2024 | Pirtobrutinib | increased | 972.23 | 100 |
| Jemperli | 01/01/2024 | Dostarlimab-Gxly | increased | 972.23 | 100 |
| Jemperli | 01/01/2024 | Dostarlimab-Gxly | increased | 972.23 | 100 |
| Jevtana | 01/01/2024 | Cabazitaxel | increased | 972.23 | 100 |
| Jevtana | 01/01/2024 | Cabazitaxel | increased | 972.23 | 100 |
| Joenja | 01/01/2024 | Leniolisib Phosphate | increased | 972.23 | 100 |
| Joenja | 01/01/2024 | Leniolisib Phosphate | increased | 972.23 | 100 |
| Jublia | 01/01/2024 | Efinaconazole | increased | 972.23 | 100 |
| Jublia | 01/01/2024 | Efinaconazole | increased | 972.23 | 100 |
| Juluca | 01/01/2024 | Dolutegravir/Rilpivirine | increased | 972.23 | 100 |
| Juluca | 01/01/2024 | Dolutegravir/Rilpivirine | increased | 972.23 | 100 |
| Juxtapid | 01/01/2024 | Lomitapide Mesylate | increased | 972.23 | 100 |
| Juxtapid | 01/01/2024 | Lomitapide Mesylate | increased | 972.23 | 100 |
| Juxtapid | 01/01/2024 | Lomitapide Mesylate | increased | 972.23 | 100 |
| Jynarque | 01/01/2024 | Tolvaptan | increased | 972.23 | 100 |
| Jynarque | 01/01/2024 | Tolvaptan | increased | 972.23 | 100 |
| Jynneos | 01/01/2024 | Smallpox And Mpox Live Vacc/PF | increased | 972.23 | 100 |
| Jynneos | 01/01/2024 | Smallpox And Mpox Live Vacc/PF | increased | 972.23 | 100 |
| Kadcyla | 01/01/2024 | Ado-Trastuzumab Emtansine | increased | 972.23 | 100 |
| Kadcyla | 01/01/2024 | Ado-Trastuzumab Emtansine | increased | 972.23 | 100 |
| Kalbitor | 01/01/2024 | Ecallantide | increased | 972.23 | 100 |
| Kalbitor | 01/01/2024 | Ecallantide | increased | 972.23 | 100 |
| Kalydeco | 01/01/2024 | IVacaftor | increased | 972.23 | 100 |
| Kalydeco | 01/01/2024 | IVacaftor | increased | 972.23 | 100 |
| Kanjinti | 01/01/2024 | Trastuzumab-Anns | increased | 972.23 | 100 |
| Kanjinti | 01/01/2024 | Trastuzumab-Anns | increased | 972.23 | 100 |
| Kesimpta Pen | 01/01/2024 | Ofatumumab | increased | 972.23 | 100 |
| Kesimpta Pen | 01/01/2024 | Ofatumumab | increased | 972.23 | 100 |
| Keveyis | 01/01/2024 | Dichlorphenamide | increased | 972.23 | 100 |
| Keveyis | 01/01/2024 | Dichlorphenamide | increased | 972.23 | 100 |
| Kevzara | 01/01/2024 | Sarilumab | increased | 972.23 | 100 |
| Kevzara | 01/01/2024 | Sarilumab | increased | 972.23 | 100 |
| Keytruda | 01/01/2024 | Pembrolizumab | increased | 972.23 | 100 |
| Keytruda | 01/01/2024 | Pembrolizumab | increased | 972.23 | 100 |
| Kimyrsa | 01/01/2024 | Oritavancin Diphosphate | increased | 972.23 | 100 |